| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 92.25▲ | 92.32▲ | 92.24▲ | 90.47▲ | 92.07▲ |
| MA10 | 92.39▼ | 92.17▲ | 91.81▲ | 90.98▲ | 91.51▲ |
| MA20 | 92.38▼ | 91.72▲ | 91.11▲ | 91.85▲ | 88.78▲ |
| MA50 | 92.16▲ | 90.59▲ | 90.60▲ | 91.83▲ | 77.89▲ |
| MA100 | 91.87▲ | 90.67▲ | 91.70▲ | 87.65▲ | 78.40▲ |
| MA200 | 91.20▲ | 91.75▲ | 91.99▲ | 78.34▲ | 73.71▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.040▼ | 0.019▲ | 0.176▲ | -0.159▼ | -0.336▼ |
| RSI | 53.272▲ | 64.182▲ | 66.358▲ | 54.043▲ | 61.435▲ |
| STOCH | 19.801▼ | 69.555 | 81.746▲ | 33.540 | 51.431 |
| WILL %R | -47.154 | -17.160▲ | -10.247▲ | -36.455 | -44.849 |
| CCI | -49.220 | 80.347 | 86.525 | 21.424 | 14.783 |
|
Monday, January 13, 2025 09:16 AM
Gilead Sciences Inc (NASDAQ: GILD) is strongly positioned to “change the face of HIV” in 2025, according to its chairman and chief executive Daniel O’Day. He dubbed lenacapavir – the company’s twice-a ...
|
|
Monday, January 13, 2025 03:00 AM
Gilead Sciences and Danish dermatology specialist LEO Pharma announced a strategic partnership, marking another move outside its traditional infectious disease area for the US antiviral giant.
|
|
Sunday, January 12, 2025 09:56 PM
Morgan Stanley upgraded shares of Gilead Sciences (NASDAQ:GILD – Free Report) from an equal weight rating to an overweight rating in a research note published on Friday, MarketBeat.com reports. Morgan Stanley currently has $113.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/01/25 | 91.29 | 92.66 | 91.29 | 92.37 | 6,950,544 |
| 14/01/25 | 90.59 | 91.48 | 89.83 | 91.00 | 7,416,400 |
| 13/01/25 | 90.30 | 90.37 | 89.02 | 89.94 | 6,521,800 |
| 10/01/25 | 90.19 | 91.43 | 88.57 | 89.88 | 7,861,600 |
| 08/01/25 | 90.68 | 90.68 | 89.00 | 89.14 | 8,045,000 |
| 07/01/25 | 91.17 | 91.50 | 90.52 | 90.61 | 4,218,647 |
| 06/01/25 | 90.75 | 91.53 | 90.33 | 91.23 | 6,779,400 |
| 03/01/25 | 92.19 | 92.34 | 91.31 | 91.41 | 4,265,200 |
| 02/01/25 | 92.62 | 92.83 | 91.40 | 91.88 | 3,495,200 |
| 31/12/24 | 92.59 | 92.98 | 91.78 | 92.37 | 3,482,500 |
|
|
||||
|
|
||||
|
|